FDA approves single-tablet regimen for HIV-1 infection in treatment-naïve adults

August 19, 2011

FDA has approved emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Complera, Gilead Sciences), a complete single-tablet regimen for the treatment of HIV-1 infection in treatment-naïve adults.

FDA approves single-tablet regimen for HIV-1 infection in treatment-naïve adults